Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19
- PMID: 32297590
- PMCID: PMC7253099
- DOI: 10.4269/ajtmh.20-0262
Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19
Conflict of interest statement
Financial support: C. E. O. and T. D. are supported by Career Development Awards from Research to Prevent Blindness.
Disclaimer: The funder had no role in the conception or writing of the manuscript or the decision to submit it for publication.
References
-
- Lim J, Jeon S, Shin H, Kim MJ, Seong YM, Lee WJ, Choe KW, Kang YM, Lee B, Park SJ, 2020. Case of the index patient who caused tertiary transmission of coronavirus disease 2019 in Korea: the application of lopinavir/ritonavir for the treatment of COVID-19 pneumonia monitored by quantitative RT-PCR. J Korean Med Sci 35: 1–6. - PubMed
-
- Iwuji CC, et al. 2018. Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial. Lancet HIV 5 e116–e125. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources